Long-term remission and monocyclic course in Still’s disease patients starting canakinumab early: data from the international AIDA network registry. // Seminars in Arthritis and Rheumatism. – URL: https://www.sciencedirect.com/science/article/pii/S0049017226001204?dgcid=rss_sd_all
Long-term remission and monocyclic course in Still’s disease patients starting canakinumab early: data from the international AIDA network registry. Seminars in Arthritis and Rheumatism. https://www.sciencedirect.com/science/article/pii/S0049017226001204?dgcid=rss_sd_all
“Long-term remission and monocyclic course in Still’s disease patients starting canakinumab early: data from the international AIDA network registry.” Seminars in Arthritis and Rheumatism.
@article{article65822,
title = {Long-term remission and monocyclic course in Still’s disease patients starting canakinumab early: data from the international AIDA network registry},
journal = {Seminars in Arthritis and Rheumatism},
url = {https://www.sciencedirect.com/science/article/pii/S0049017226001204?dgcid=rss_sd_all}
}